Cytotoxic T lymphocytes (CTLs) recognize antigens in the context of major histocompatibility complex (MHC) class I gene products. The T-cell receptor (TCR) that mediates this MHC-restricted antigen recognition recognizes short peptide fragments rather than the intact antigen. Presentation of peptides to the TCR may thus be a major function of the MHC. An intriguing question emerging from this model is whether peptide presentation also applies to foreign MHC antigens and which ofthe available MHC molecules can present preferentially the peptides of the foreign MHC molecule. Alloand xenoreactive CTLs might either recognize native MIC class I molecules or peptides presented by self MHC or by the foreign class I MHC itself. The finding that synthetic peptides corresponding to MHC class I regions are recognized by alloand xenoreactive CTLs suggests that recognition of foreign MHC by CTLs might involve degraded fragments presented by syngeneic class I molecules. We used MHC transgenic mice as a tool to study these questions. The CTL responses against human (HLA) antigen B27 were analyzed by using HLA-B27
In recent years, it has been established that peptides derived from processed antigens are bound to the peptide-binding site of major histocompatibility complex (MHC) molecules and are then presented to the T-cell receptor (TCR). The crystallographic structure of a class I molecule shows the peptidebinding site as a deep groove between the a-helices of the a, and a2 domains (1, 2) . The observation that the majority of MHC polymorphic residues are located in the peptidebinding site suggests that alloreactivity may reflect the recognition of a complex between the allo-MHC and some peptide (2) . Such a peptide could be derived from the foreign MHC itself or from another molecule. Alternatively, self MHC molecules expressed on the membrane may bind the foreign MHC peptides. A consequence of the latter possibility would be that the recognition of the foreign MHC peptide is restricted by self MHC. However, the possibility remains that the TCR recognizes native allo-or xeno-MHC molecules rather than peptides.
In the mouse, syngeneic H-2-restricted recognition of HLA antigens has been frequently reported (3) (4) (5) (6) (7) . Most of the experiments were done with selected cytotoxic T-lymphocyte (CTL) clones and lines raised against HLA-transfected mouse cells. Such CTLs might represent only a minimal part of the T-cell repertoire. Therefore, we examined whether mouse bulk CTL populations, directed against xeno-MHC HLA molecules, were restricted by the mouse MHC.
MATERIALS AND METHODS
Mice. The mouse strains were maintained at our institute. The origin and functional and biochemical analysis of the HLA-B27 and SLA-PD1 (human and porcine) xeno-MHC products in transgenic mice have been described (8) (9) (10) ). H-2b, H-2, H2k, and H22d B27dTGM (double transgenic mice with human 62-microglobulin and HLA-B27K genes) were obtained from crosses between B27dTGM mice and B10, B10.Q, B10.BR, and B10.D2(n) mice, respectively. The SLA-PDlsTGM (single transgenic mice with the PD1 allele of SLA) are of B10 (H-2b) origin (8) . H-2k SLA-PD1 TGM were obtained from crosses to B10.BR (H-2k) mice.
CTLs. Spleen cells from naive B10, B10.Q, B10.BR, or B10.D2 mice were cocultured with the same number of irradiated (2300 rad; 1 rad = 0.01 Gy) spleen cells from H-2-matched B27dTGM or PD1sTGM. This was done in 50 ml of Iscove's modified Dulbecco's medium, supplemented with 10% (vol/vol) fetal calf serum and penicillin (100 units/ml), streptomycin (100 ,ug/ml), and 5 x 10-5 M 2-mercaptoethanol. Autologous transgenic lymph node cells were cultured in the same medium and used as target cells. After 5 days, the responding CTLs were collected and tested in the 51Cr release assay on human transgenic and nontransgenic cells stimulated for 3 days with concanavalin A (2.5 ,g/ml). Responding CTLs were incubated with 5'Cr-labeled target cells at the effector/target ratio indicated.
For antibody-blocking experiments, target cells were incubated for 30 min on ice with 100 ,ul of monoclonal antibody (mAb) (1:10) and washed three times with medium before incubation with CTLs. The anti-HLA mAb W6/32 and anti-H-2 mAb Q-1 (11) were used, because they can effectively inhibit allo-CTLs and do not crossreact with H-2k and HLA-B27, respectively. Lysis of target cells expressing SLA-PD1 was blocked by PD1-specific mAb 74- 11-10 (12 The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
(release in the presence of CTL spontaneous release)/ (release in 10% Triton X-100 spontaneous release) x 100%. The spontaneous release in medium from labeled target cells ranged from 20% to 30% of the maximal release produced by Triton X-100.
For the primed CTL response, responder mice were injected intraperitoneally with one injection of 5 x 106 lymph node cells 3 weeks before the in vitro assay. CTL precursor frequencies (CTLpf) were estimated in limiting-dilution analysis by techniques described elsewhere (13) .
Human Lymphocytes. HLA-typed lymphocytes were isolated from human peripheral blood by flotation on FicollIsopaque and stored in liquid nitrogen until used. HLA types of the human cells were HLA-A2, -8; B27K, -27K; C2, -; DR2, -5 (27, 27): HLA-A3, -21; B27K, -61; C2, -2; DR8, -5 (27, -): HLA-2, -31; B18, -62; C3, -; DR4, -8 (-, -): HLA-A2, -28; B5, -12; C4, -(-, -).
RESULTS
The CTL response against xenogeneic MHC determinants on cells of mice double transgenic for the human genes HLA-B27K and ,82-microglobulin (B27dTGM) was studied. HLA-B27-specific CTLs were elicited by stimulation in vitro of H-2b, H-2q, H-2k, or H-2d spleen cells ( Fig. 1 ) with irradiated cells from B27dTGM cells of matched H-2 haplotypes. The specificity of the CTL population(s) was tested on HLA-B27-positive and -negative human cells ( Fig. 1 A, C, and D) . The anti-HLA-B27 CTLs were able to kill only HLA-B27-positive human cells and the level of specific lysis was dependent on whether the target cells were homozygous or heterozygous for HLA-B27 (Fig. 1A) . These results already show that the recognition of HLA-B27 xenogeneic MHC molecules by mouse CTLs occurred in a non-H-2-restricted way. The same CTL population(s) was perfectly able to kill HLA-B27-positive H-2-matched cells, whereas HLA-B27-negative H-2-matched cells were not lysed. Moreover, the same CTL populations were examined on H-2-mismatched B27dTGM mouse cells (in each experiment on one or two H-2-mismatched B27dTGM target cells; Fig. 1 A, B, C, and D, respectively). Again, in all combinations, cells expressing HLA-B27 were lysed, whereas no lysis was observed on HLA-B27-negative cells. No H-2 restriction in the recognition of HLA-B27 was found.
In the combination H-2k-anti-H-2kB27dTGM, the specificity of the CTL recognition was analyzed by antibody blocking and cold target inhibition experiments. Fig. 2A shows that lysis of B27dTGM cells could be blocked by anti-HLA but not by anti-H-2 antibodies and, second, that human B27-positive cells could block lysis of B27dTGM mouse cells. Fig. 2B shows the same but for the lysis of B27dTGM cells with the H-2 q haplotype. Hence, recognition of B27 on H-2-matched (H-2k) and H-2-mismatched (H-2q) cells could be completely inhibited by anti-HLA antibody and by B27-positive human cells.
Furthermore, we estimated in limiting-dilution analysis the CTLpf for H-2-restricted and nonrestricted response to B27dTGM cells. The CTLpf in H-2b and H-2q mice specific for H-2-matched and -mismatched B27dTGM cells is -1 in 105 spleen cells. This value is -100 times lower than the CTLpf seen in naive animals after allogeneic stimulation. The CTLpf specific for H-2-matched transgenic cells (i.e., self H-2-restricted) in the same H-2b and H-2q mice was undetectable (<1/106). Taken together, these results show that mice are perfectly able to generate xeno-MHC-specific CTLs in primary response against transgenic cells.
Analogous experiments were performed also in primed mice. Fig. 3A shows that H-2k-anti-H-2kB27dTGM CTLs from mice primed by one injection of B27dTGM cells lysed specifically B27-positive human cells and H-2kB27dTGM cells. Moreover, H-2-mismatched H-29B27dTGM and H2bB27dTGM cells were also lysed. Compared with the results from unprimed mice (Fig. 1) , the percentage specific lysis was about 2 times higher with CTLs from in vivo primed mice. Still, these bulk CTLs could also be blocked by anti-HLA and human B27-positive cells (Fig. 3B ). 
DISCUSSION
Recognition of foreign antigens, like haptens, viral, tumor, or minor histocompatibility antigens by T cells, is restricted by self MHC. The T-cell precursor frequency is low and priming in vivo is necessary before stimulation in vitro. This is in contrast with the nonrestricted recognition of allogeneic MHC determinants. The T-cell precursor frequency is high and stimulation occurs directly in primary lymphocyte cultures. It has been hypothesized that when foreign MHC antigens are seen as alloantigens by T cells, they are almost invariably associated with self or foreign non-MHC peptides (14) . This interpretation argues that when T cells are confronted with allogeneic MHC determinants, they will respond to the myriad of complexes formed by non-MHC surface structures and the allogeneic MHC. This might explain the high frequency of such alloreactive T cells (15) (16) (17) . Some experiments that showed the activation of T cells by purified MHC antigens attached to synthetic beads suggest that alloreactive T cells recognize MHC alone (18) . However, the possibility that these T cells recognize a peptide adduct persistently associated with purified soluble HLA antigens (1, 2) has not been ruled out. The observation that HLA-A2-specific CTLs were able to recognize HLA-A2-derived peptides only when the peptides were presented by HLA molecules closely related to HLA-A2 (19) indicate that recognition of allogeneic MHC may include recognition of peptides preferentially presented by their native MHC molecule. The high frequency of alloreactive T cells must then be explained in terms of concentration of MHC epitopes on cell surfaces (20) .
A number of previous reports have dealt with the recognition of HLA antigens by mouse CTLs (3-7). These authors have concluded that HLA is generally recognized by mouse T cells as a nominal antigen in the context of a self H-2 class I restriction element. This implies that xenogeneic MHC determinants are not recognized in the same way as alloantigens. This conclusion has been based on the reactivity pattern of some selected CTL clones and CTL lines obtained after priming in vivo with HLA-transfected cells. Xenogeneic responses induced in such a way are often accompanied by responses against viral, tumor, or "minor" antigens and are therefore not representative for a classical MHC class Ispecific response.
In the experiments described here, the availability of HLA-B27 and SLA-PD1 transgenic mice allowed us to test whether xenoreactive CTLs, in analogy with alloreactive CTLs, preferentially recognize their antigens in a non-H-2-restricted way. Our results show that this is indeed the case. Although the xeno-CTLpf is much lower than the allo-CTLpf, the results show that xeno-MHC antigens are 
